With California and other states likely to vote on full cannabis legalization, decisions made in 2016 may well shape the future of cannabis policy for a generation or more. At the same time, scientific knowledge about the effects of cannabis on its users, and of cannabis policies on cannabis use and other outcomes, continues to grow. Now is the time to bring scientists and policy-makers together for a thoughtful consideration of the likely gains and losses from pursuing one option rather than another. You are cordially invited to join over 350 highly regarded researchers, policy-makers and entrepreneurs for a two-day event on April 17 and 18 at the The Cannabis Science and Policy Summit.
The Cannabis Science and Policy Summit puts the following questions on the public agenda:
- Four states now allow commercial production of cannabis, another 20 have medical marijuana programs. Where is the rest of the country heading?
How can you shrink the $40 billion per year black market—the largest illicit market—without swelling the ranks of cannabis users?
What can law enforcement and policy-makers do about impaired driving under legalization?
Will legalization have an impact on educational outcomes?
Presenters and hosts will include:
Mark Kleiman, Professor of Public Policy, NYU Marron Institute of Urban Management
Thomas Schelling, Professor Emeritus, Harvard & University of Maryland, Nobel Laureate in Economics
Rosalie Pacula, Vice President of the International Society for the Study of Drug Policy
John Walsh, Senior Associate at WOLA
Alex Stevens, President of the International Society for the Study of Drug Policy
The event will take place at the Graduate Center, 34th Street & 5th Avenue, New York and you can register online here.
More information on the event can be viewed here.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.